Latest Commercialisation News

Page 103 of 116
Toro Energy has completed a critical re-optimisation of the Lake Maitland mining pit, paving the way for detailed mine scheduling as part of its 2025 scoping study update. This progress reflects updated resource estimates and financial assumptions, signaling a key step forward for the Wiluna Uranium Project.
Maxwell Dee
Maxwell Dee
6 Feb 2025
ImpediMed Limited has locked in a US$15 million growth capital facility with SWK Funding LLC, providing crucial financial flexibility to advance its SOZO Digital Health Platform and commercial ambitions.
Ada Torres
Ada Torres
6 Feb 2025
Vitrafy Life Sciences reports strong progress in cryopreservation technology development and US market expansion following a successful $35 million IPO. The company highlights improved biological sample preservation outcomes and strategic commercial milestones.
Victor Sage
Victor Sage
6 Feb 2025
Vitrafy Life Sciences reported a dramatic increase in half-year losses to $25.7 million, yet successfully raised $35 million through an IPO to fuel its cryopreservation technology expansion.
Ada Torres
Ada Torres
6 Feb 2025
Neurizon Therapeutics has been granted a pivotal US patent for its lead drug candidate NUZ-001, extending protection until 2039 and enhancing its commercial and clinical positioning in neurodegenerative disease treatment.
Ada Torres
Ada Torres
5 Feb 2025
Audeara Limited has landed a significant US$917,000 follow-up purchase order from a global music instrument manufacturer, reinforcing the commercial viability of its hearing technology and expanding its licensing footprint.
Ada Torres
Ada Torres
5 Feb 2025
Biome Australia has partnered with the Food and Beverage Accelerator (FaBA) to jointly develop its promising BMB18 probiotic strain, leveraging $50 million in Australian government funding while retaining full IP ownership.
Victor Sage
Victor Sage
5 Feb 2025
Green Critical Minerals Limited has launched an offer of up to 10,000 Listed Options at no cost to remove trading restrictions on previously issued options, aiming to facilitate secondary trading and enhance liquidity for investors.
Maxwell Dee
Maxwell Dee
4 Feb 2025
Bio-Gene Technology Limited has secured A$3 million in U.S. Department of Defense grants to accelerate development of its two nature-derived insecticides, Flavocide and Qcide, targeting both military and civilian markets.
Ada Torres
Ada Torres
4 Feb 2025
Rhythm Biosciences has fast-tracked the integration of the geneType™ business, restoring full commercial capabilities ahead of schedule and setting the stage for expanded market reach.
Ada Torres
Ada Torres
4 Feb 2025
WAT Resources Ltd has successfully produced ferroniobium from its Luni niobium concentrate, marking a key milestone in the West Arunta Project’s development. The proof-of-concept testwork confirms the viability of a conventional production process and sets the stage for further optimisation and product diversification.
Maxwell Dee
Maxwell Dee
4 Feb 2025
Entyr Limited has received a $3.79 million R&D tax incentive payment for its innovative thermal desorption project targeting rubber waste, reinforcing its position in sustainable tyre recycling technology.
Victor Sage
Victor Sage
3 Feb 2025